American Journal of Cardiology
Volume 103, Issue 6 , Pages 796-800 , 15 March 2009

Arterial Access-Site–Related Outcomes of Patients Undergoing Invasive Coronary Procedures for Acute Coronary Syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non–ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy)

Received 20 October 2008 ,Revised 13 November 2008 ,Accepted 13 November 2008.

References 

  1. Eikelboom JW, Metha SR, Anand SS, Xie C, Fox KAA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774–782
  2. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew AP, Bittl JA, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol. 2007;100:1364–1369
  3. Manoukian SV, Feit F, Meharan R, Voeltz MD, Ebrahimi R, Hamon M, et al Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes. J Am Coll Cardiol. 2007;49:1362–1368
  4. Archbold RA, Robinson NM, Schilling RJ. Radial artery access for coronary angiography and percutaneous coronary intervention. BMJ. 2004;329:443–446
  5. Agostoni P, Biondi-Zoccai GGL, De Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures. J Am Coll Cardiol. 2004;44:349–356
  6. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernàndez-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598–1660
  7. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al Key elements and data definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards. J Am Coll Cardiol. 2001;38:2114–2130
  8. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, et al Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pre-treatment: the ISAR-REACT 2 randomized trial. JAMA. 2006;295:1531–1538
  9. Ndrepepa G, Kastrati A, Mehilli J, Neumann FJ, ten Berg J, Bruskina O, et al. One-year clinical outcomes with abciximab vs placebo in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial. Eur Heart J. 2008;29:455–461
  10. The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med. 1998;338:1488–1497
  11. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436–443
  12. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  13. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–1562
  14. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schömig A, et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions. J Am Coll Cardiol. 2008;51:690–697
  15. Stone GW, Mc Laurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, et al Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203–2216
  16. Montalescot G, White HD, Gallo R, Cohen M, Steg PG, Aylward PE, et al Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventions. N Engl J Med. 2006;355:1006–1017
  17. Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, et al Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal. Cathet Cardiovasc Interv. 2007;69:73–83
  18. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, et al. The association of arterial access site at angioplasty with transfusion and mortality: the MORTAL Study. Heart. 2008;94:1019–1025
  19. Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol. 2007;30:1742–1751

PII: S0002-9149(08)02095-X

doi: 10.1016/j.amjcard.2008.11.049

American Journal of Cardiology
Volume 103, Issue 6 , Pages 796-800 , 15 March 2009

Article Tools

* Image Usage & Resolution